Lymphoma cell metabolism may provide new cancer target

Gabrielle’s Angels grantee Dr. Ari Melnick of Weill Cornell and his team have recently discovered that aggressive and relatively common lymphomas called diffuse large B cell lymphomas have a critical metabolic vulnerability that can be exploited to trick these cancers into starving themselves. This is a huge breakthrough with many possibilities for future therapeutic applications!